Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Nucleic Acids Res ; 38(12): 4120-32, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20194115

ABSTRACT

Sgm (Sisomicin-gentamicin methyltransferase) from antibiotic-producing bacterium Micromonospora zionensis is an enzyme that confers resistance to aminoglycosides like gentamicin and sisomicin by specifically methylating G1405 in bacterial 16S rRNA. Sgm belongs to the aminoglycoside resistance methyltransferase (Arm) family of enzymes that have been recently found to spread by horizontal gene transfer among disease-causing bacteria. Structural characterization of Arm enzymes is the key to understand their mechanism of action and to develop inhibitors that would block their activity. Here we report the structure of Sgm in complex with cofactors S-adenosylmethionine (AdoMet) and S-adenosylhomocysteine (AdoHcy) at 2.0 and 2.1 A resolution, respectively, and results of mutagenesis and rRNA footprinting, and protein-substrate docking. We propose the mechanism of methylation of G1405 by Sgm and compare it with other m(7)G methyltransferases, revealing a surprising diversity of active sites and binding modes for the same basic reaction of RNA modification. This analysis can serve as a stepping stone towards developing drugs that would specifically block the activity of Arm methyltransferases and thereby re-sensitize pathogenic bacteria to aminoglycoside antibiotics.


Subject(s)
Bacterial Proteins/chemistry , Methyltransferases/chemistry , RNA, Ribosomal, 16S/chemistry , Amino Acid Sequence , Aminoglycosides/pharmacology , Anti-Bacterial Agents/biosynthesis , Anti-Bacterial Agents/pharmacology , Base Sequence , Calorimetry , Catalytic Domain , Conserved Sequence , Drug Resistance, Bacterial , Methylation , Micromonospora/enzymology , Models, Molecular , Molecular Sequence Data , RNA, Ribosomal, 16S/metabolism , Ribosome Subunits, Small, Bacterial/chemistry , S-Adenosylhomocysteine/chemistry , S-Adenosylmethionine/chemistry , Sequence Homology, Amino Acid
2.
Article in English | MEDLINE | ID: mdl-19407396

ABSTRACT

Serine proteases play a major role in host-pathogen interactions. The innate immune system is known to respond to invading pathogens in a nonspecific manner. The serine protease cascade is an essential component of the innate immune system of the horseshoe crab. The serine protease inhibitor CrSPI isoform 1 (CrSPI-1), a unique nonclassical Kazal-type inhibitor of molecular weight 9.3 kDa, was identified from the hepatopancreas of the horseshoe crab Carcinoscorpius rotundicauda. It potently inhibits subtilisin and constitutes a powerful innate immune defence against invading microbes. Here, the cloning, expression, purification and cocrystallization of CrSPI-1 with subtilisin are reported. The crystals diffracted to 2.6 A resolution and belonged to space group P2(1), with unit-cell parameters a = 73.8, b = 65.0, c = 111.9 A, beta = 95.4 degrees . The Matthews coefficient (V(M) = 2.64 A(3) Da(-1), corresponding to 53% solvent content) and analysis of the preliminary structure solution indicated the presence of one heterotrimer (1:2 ratio of CrSPI-1:subtilisin) and one free subtilisin molecule in the asymmetric unit.


Subject(s)
Horseshoe Crabs/chemistry , Horseshoe Crabs/metabolism , Serine Proteinase Inhibitors/chemistry , Serine Proteinase Inhibitors/metabolism , Subtilisin/chemistry , Subtilisin/metabolism , Animals , Chromatography, Gel , Crystallization , Crystallography, X-Ray , Horseshoe Crabs/genetics , Protein Binding , Serine Proteinase Inhibitors/genetics , Serine Proteinase Inhibitors/isolation & purification
3.
J Med Chem ; 51(5): 1361-8, 2008 Mar 13.
Article in English | MEDLINE | ID: mdl-18278855

ABSTRACT

We report a series of noncovalent, reversible inhibitors of cathepsin L that have been designed to explore additional binding interactions with the S' subsites. The design was based on our previously reported crystal structure that suggested the possibility of engineering increased interactions with the S' subsites ( Chowdhury et al. J. Med. Chem. 2002, 45, 5321-5329 ). A representative of these new inhibitors has been co-crystallized with mature cathepsin L, and the structure has been solved and refined at 2.2 A. The inhibitors described in this work extend farther into the S' subsites of cathepsins than any inhibitors reported in the literature thus far. These interactions appear to make use of a S3' subsite that can potentially be exploited for enhanced specificity and/or affinity.


Subject(s)
Cathepsins/antagonists & inhibitors , Cysteine Proteinase Inhibitors/chemistry , Models, Molecular , Arginine/analogs & derivatives , Arginine/chemistry , Binding Sites , Biphenyl Compounds/chemistry , Cathepsin L , Cathepsins/chemistry , Crystallography, X-Ray , Cysteine Endopeptidases/chemistry , Phenylalanine/analogs & derivatives , Phenylalanine/chemistry , Protein Binding , Static Electricity , Tyrosine/analogs & derivatives , Tyrosine/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...